The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
Open accessAbstract
BACKGROUND & AIMS: An association between diabetes and chronic liver disease has been reported. However, the temporal relationship between these conditions remains unknown. METHODS: We identified all patients with a hospital discharge diagnosis of diabetes between 1985 and 1990 using the computerized records of the Department of Veterans Affairs. We randomly assigned 3 patients without diabetes for every patient with diabetes. We excluded patients with concomitant liver disease. The remaining cohort was followed through 2000 for the occurrence of chronic nonalcoholic liver disease (CNLD) and hepatocellular carcinoma (HCC). Hazard rate ratios (HRR) were determined in Cox proportional hazard survival analysis. RESULTS: The study cohort comprised 173,643 patients with diabetes and 650,620 patients without diabetes. Most were men (98%). Patients with diabetes were older (62 vs. 54 years) than patients without diabetes. The incidence of chronic nonalcoholic liver disease was significantly higher among patients with diabetes (incidence rate: 18.13 vs. 9.55 per 10,000 person-years, respectively, P < 0.0001). Similar results were obtained for HCC (incidence rate: 2.39 vs. 0.87 per 10,000 person-years, respectively, P < 0.0001). Diabetes was associated with an HRR of 1.98 (95% CI: 1.88 to 2.09, P < 0.0001) of CNLD and an HRR of 2.16 (1.86 to 2.52, P < 0.0001) of hepatocellular carcinoma. Diabetes carried the highest risk among patients with longer than 10 years of follow-up. CONCLUSIONS: Among men with diabetes, the risk of CNLD and HCC is doubled. This increase in risk is independent of alcoholic liver disease, viral hepatitis, or demographic features.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Self-citationLee, J. A. H. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03370120114036 · Cited by 2,243
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli-Labate, A. M., Bianchi, G., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,568
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis
Harris, M. I., Klein, R., Welborn, T. A., & Knuiman, M. W. (1992) · Diabetes Care · doi:10.2337/diacare.15.7.815 · Cited by 1,306
Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
Falck-Ytter, Y., Younossi, Z. M., Marchesini, G., & McCullough, A. J. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12926 · Cited by 673
Etiopathogenesis of Nonalcoholic Steatohepatitis
Chitturi, S., & Farrell, G. C. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12927 · Cited by 661
Wideroff, L., Gridley, G., Chow, W. H., Linet, M., Mellemkjaer, L., Olsen, J. H., Keehn, S., & Borch-Johnsen, K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.18.1360 · Cited by 627
Ruhl, C. E., & Everhart, J. E. (2003) · Gastroenterology · doi:10.1053/gast.2003.50004 · Cited by 596
Self-citationBurden of liver disease in the United States: Summary of a workshop
Kim, R. W., Brown, R. S., Terrault, N. A., & El-Serag, H. (2002) · Hepatology · doi:10.1053/jhep.2002.34734 · Cited by 589
Self-citationPrevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
Poonawala, A., Nair, S. P., & Thuluvath, P. J. (2000) · Hepatology · doi:10.1053/jhep.2000.17894 · Cited by 569
Nonalcoholic steatohepatitis: A study of 49 patients
Lee, R. G. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90249-9 · Cited by 550
Risk Factors for the Rising Rates of Primary Liver Cancer in the United States
El-Serag, H. B., & Mason, A. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3227 · Cited by 418
Self-citationMitochondria in Steatohepatitis
Pessayre, D., Berson, A., Fromenty, B., & Mansouri, A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12929 · Cited by 391
Excess Risk of Primary Liver Cancer in Patients With Diabetes Mellitus
Adami, H.-O., Chow, W.-H., Nyren, O., Berne, C., Linet, M. S., Ekbom, A., Wolk, A., McLaughlin, J. K., & Fraumeni, J. F. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1472 · Cited by 373
GLUCOSE TOLERANCE AND DIABETES IN CHRONIC LIVER DISEASE
Megyesi, C., Samols, E., & Marks, V. (1967) · The Lancet · doi:10.1016/s0140-6736(67)90334-0 · Cited by 356
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Shimada, M., Hashimoto, E., Taniai, M., Hasegawa, K., Okuda, H., Hayashi, N., Takasaki, K., & Ludwig, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00099-5 · Cited by 356
A case-control study of diabetes mellitus and cancer risk
La Vecchia, C., Negri, E., Franceschi, S., D'Avanzo, B., & Boyle, P. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.427 · Cited by 320
Cancer risk in patients with diabetes mellitus
Adami, H.-O., McLaughlin, J., Ekbom, A., Berne, C., Silverman, D., Hacker, D., & Persson, I. (1991) · Cancer Causes and Control · doi:10.1007/bf00051670 · Cited by 319
The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans
El-Serag, H. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02617-x · Cited by 274
Self-citationKashner, T. M. (1998) · Medical Care · doi:10.1097/00005650-199809000-00005 · Cited by 264
Ragozzino, M., Melton, L. J., Chu, C.-P., & Palumbo, P. J. (1982) · Journal of Chronic Diseases · doi:10.1016/0021-9681(82)90025-x · Cited by 222
Cancer Mortality Among Diabetics 2
(1970) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/44.3.673 · Cited by 212
Yu, M. C., Henderson, B. E., Tong, M. J., & Govindarajan, S. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1820 · Cited by 190
Metabolic and nutritional considerations in nonalcoholic fatty liver
Fong, D. G., Nehra, V., Lindor, K. D., & Buchman, A. L. (2000) · Hepatology · doi:10.1053/jhep.2000.8978 · Cited by 178
Hepatocellular carcinoma arising in non‐alcoholic steatohepatitis
Zen, Y., Katayanagi, K., Tsuneyama, K., Harada, K., Araki, I., & Nakanuma, Y. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01174.x · Cited by 174
Role of Diabetes Mellitus in the Etiology of Hepatocellular Carcinoma
Lagiou, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.13.1096 · Cited by 162
Diabetes mellitus and the risk of primary liver cancer
Vecchia, C. L., Negri, E., Decarli, A., & Franceschi, S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971009)73:2<204::aid-ijc7>3.0.co;2-# · Cited by 145
Bisceglie, A. M. D., Carithers, R. L., & Gores, G. J. (1998) · Hepatology · doi:10.1002/hep.510280436 · Cited by 142
Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Natural History?
Cotrim, H. P., Paraná, R., Braga, E., & Lyra, L. G. C. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03241.x · Cited by 128
A case-control study of primary hepatocellular carcinoma in Taiwan
Lu, S., Lin, T., Chen, C., Chen, J. S., Liaw, Y., Chang, W., & Hsu, S. T. (1988) · Cancer · doi:10.1002/1097-0142(19881101)62:9<2051::aid-cncr2820620930>3.0.co;2-1 · Cited by 110
US Department of Veterans Affairs Medical Care System as a Resource to Epidemiologists
Boyko, E. J., Koepsell, T. D., Gaziano, J. M., Horner, R. D., & Feussner, J. R. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010207 · Cited by 109
Page, W. F., Mahan, C. M., & Kang, H. K. (1996) · Annals of Epidemiology · doi:10.1016/1047-2797(95)00126-3 · Cited by 108
Conn, H. O., Schreiber, W., & Elkington, S. G. (1971) · Digestive Diseases and Sciences · doi:10.1007/bf02235244 · Cited by 101
Diabetes mellitus in chronic active hepatitis and cirrhosis
Kingston, M. E., Ali, M. A., Atiyeh, M., & Donnelly, R. J. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90544-4 · Cited by 96
Prospective study of diabetes mellitus and liver cancer in Japan
Fujino, Y., Mizoue, T., Tokui, N., & Yoshimura, T. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.214 · Cited by 85
Diabetes Mellitus and Primary Hepatocellular Carcinoma
Lawson, D. H., Gray, J. M., McKillop, C. A., CLARKE, J., LEE, F. D., & Patrick, R. S. (1986) · QJM · doi:10.1093/oxfordjournals.qjmed.a068053 · Cited by 83
Insulin Resistance in Obesity: Metabolic Mechanisms and Measurement Methods
Belfiore, F., & Iannello, S. (1998) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2727 · Cited by 79
Diabetes Mellitus May Be Associated with Hepatocarcinogenesis in Patients with Chronic Hepatitis C
Tazawa, J., Maeda, M., Nakagawa, M., Ohbayashi, H., Kusano, F., Yamane, M., Sakai, Y., & Suzuki, K. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1014715327729 · Cited by 79
Medical history and primary liver cancer.
Vecchia, C. L., Negri, E., D’Avanzo, B., Boyle, P., & Franceschi, S. (1990) · PubMed · Cited by 64
Attributable risks for hepatocellular carcinoma in Northern Italy
Braga, C., Vecchia, C. L., Negri, E., & Franceschi, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00500-x · Cited by 61
Conn, H. O., Schreiber, W., Elkington, S. G., & Johnson, T. R. (1969) · Digestive Diseases and Sciences · doi:10.1007/bf02233205 · Cited by 56
1 Liver disease, carbohydrate metabolism and diabetes
Shmueli, E., Record, C. O., & Alberti, K. G. M. M. (1992) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80163-6 · Cited by 39
Cited by
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Self-citationStandards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
“In a prospective analysis, diabetes was significantly associated with incident nonalcoholic chronic liver disease and with hepatocellular carcinoma (482).”
BackgroundStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Self-citation
Metadata
- Authors
- El-serag, H. B., Tran, T., & Everhart, J. E.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 126
- Issue
- 2
- Pages
- 460-468
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1988051941
- Cited by
- 1,230
- References
- 48
- FWCI
- 32.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.